BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28899788)

  • 21. Myelin basic protein in experimental allergic encephalomyelitis is not affected at the posttranslational level: implications for demyelinating disease.
    Mastronardi FG; al-Sabbagh A; Nelson PA; Rego J; Roots BI; Moscarello MA
    J Neurosci Res; 1996 May; 44(4):344-9. PubMed ID: 8739153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis.
    Cong H; Zhang M; Chang H; Du L; Zhang X; Yin L
    Eur J Pharmacol; 2020 Oct; 885():173523. PubMed ID: 32871176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
    Garay LI; González Deniselle MC; Brocca ME; Lima A; Roig P; De Nicola AF
    Neuroscience; 2012 Dec; 226():40-50. PubMed ID: 23000619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Durose WW; Shimizu T; Li J; Abe M; Sakimura K; Chetsawang B; Tanaka KF; Suzumura A; Tohyama K; Ikenaka K
    J Neurochem; 2019 Feb; 148(3):413-425. PubMed ID: 30152001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
    Nack A; Brendel M; Nedelcu J; Daerr M; Nyamoya S; Beyer C; Focke C; Deussing M; Hoornaert C; Ponsaerts P; Schmitz C; Bartenstein P; Rominger A; Kipp M
    Cells; 2019 Jan; 8(2):. PubMed ID: 30696113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.
    Oxombre B; Lee-Chang C; Duhamel A; Toussaint M; Giroux M; Donnier-Maréchal M; Carato P; Lefranc D; Zéphir H; Prin L; Melnyk P; Vermersch P
    Br J Pharmacol; 2015 Apr; 172(7):1769-82. PubMed ID: 25521311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis.
    al-Sabbagh AM; Goad EP; Weiner HL; Nelson PA
    J Neurosci Res; 1996 Aug; 45(4):424-9. PubMed ID: 8872902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
    Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
    Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
    J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis.
    Pifarre P; Prado J; Baltrons MA; Giralt M; Gabarro P; Feinstein DL; Hidalgo J; Garcia A
    Acta Neuropathol; 2011 Apr; 121(4):499-508. PubMed ID: 21234581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
    Khan N; Woodruff TM; Smith MT
    Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.
    Karlstetter M; Nothdurfter C; Aslanidis A; Moeller K; Horn F; Scholz R; Neumann H; Weber BH; Rupprecht R; Langmann T
    J Neuroinflammation; 2014 Jan; 11():3. PubMed ID: 24397957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progesterone treatment modulates mRNA OF neurosteroidogenic enzymes in a murine model of multiple sclerosis.
    Garay L; Gonzalez Giqueaux P; Guennoun R; Schumacher M; Gonzalez Deniselle MC; De Nicola AF
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):421-429. PubMed ID: 27597394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.